This Article Full Text Full Text (PDF) Supplementary Data All Versions of this Article: 0008-5472.CAN-08-2354v1 69/6/2279    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Leroy, C. Articles by Roche, S. Search for Related Content PubMed PubMed Citation Articles by Leroy, C. Articles by Roche, S.

Quantitative Phosphoproteomics Reveals a Cluster of Tyrosine Kinases That Mediates Src Invasive Activity in Advanced Colon Carcinoma Cells

¹ Centre National de la Recherche Scientifique UMR5237, University of Montpellier 1 and 2, CRBM, ² UMR 5203 Institut National de la Santé et de la Recherche Médicale U661, University of Montpellier 1 and 2, IGF, and ³ Institut National de la Santé et de la Recherche Médicale U896, IRCM, CRCL Val d'Aurelle Paul Lamarque, University of Montpellier 1 and 2, Montpellier, France

Requests for reprints: Serge Roche, CRBM, UMR5237, 1919 route de Mende, 34293 Montpellier Cedex 05, France. Phone: 33-467-61-33-73l; Fax: 33-467-52-15-59; E-mail: Serge.Roche{at}crbm.cnrs.fr.

Key Words: oncogenic signaling • phosphoproteomics • tyorsine kinase Src

The nonreceptor tyrosine kinase Src is frequently overexpressed and/or activated in human colorectal carcinoma (CRC), and its increased activity has been associated with a poor clinical outcome. Src has been implicated in growth and invasion of these cancer cells by still not well-known mechanisms. Here, we addressed Src oncogenic signaling using quantitative phosphoproteomics. Src overexpression increased growth and invasiveness of metastatic SW620 CRC cells. Stable isotope labeling with amino acids in cell culture in combination with liquid chromatography tandem mass spectrometry allowed the identification of 136 proteins which exhibited a significant increase in and/or association with tyrosine phosphorylation upon Src expression. These mainly include signaling, cytoskeleton, and vesicular-associated proteins. Interestingly, Src also phosphorylated a cluster of tyrosine kinases, i.e., the receptors Met and EphA2, the cytoplasmic tyrosine kinase Fak, and pseudo-tyrosine kinase SgK223, which were required for its invasive activity. Similar results were obtained with metastatic Colo205 CRC cells that exhibit high endogenous Src activity. We concluded that Src uses a tyrosine kinases network to promote its invasive activity in CRC and this implicates a reverse signaling via tyrosine kinase receptors. Targeting these tyrosine kinases may be of significant therapeutic value in this cancer. [Cancer Res 2009;69(6):2279–86]